We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The business environment for pharmaceutical companies in China is generally favorable. China has a large population and a growing middle class, which creates a significant demand for healthcare and pharmaceutical products.
On August 13th, the State Council issued the "Opinions on Further Optimizing the Foreign Investment Environment and Increasing the Attractiveness of Foreign Investment" (hereinafter referred to as the "Opinions").
Anupam Rasayan, custom synthesis and specialty chemical player, informed that it has received and signed contracts amounting to Rs 540 crores from two multinational companies dealing in the fields of life sciences chemicals.